Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
Subscribe To Our Newsletter & Stay Updated